Ceftriaxone therapy for staphylococcal osteomyelitis: a review.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10619757.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ceftriaxone, although less active than standard antistaphylococcal agents, is potentially useful in the treatment of osteomyelitis. Thirty-one patients with osteomyelitis due to Staphylococcus aureus were identified, 22 of whom were treated with ceftriaxone and 9 with other agents. Of those patients treated with ceftriaxone, 17 were cured; all treatment failures were associated with chronic osteomyelitis and continued presence of necrotic bone or infected hardware. It is concluded that ceftriaxone is effective in the ambulatory treatment of S. aureus osteomyelitis.
Medical subject headings
- Ceftriaxone
- Cephalosporins
- Osteomyelitis
- Staphylococcal Infections